www.pharmablog.nl
Weblog met nieuws over de pharmaceutische industrie
Archive for October, 2008
De psychiater doet niet genoeg tegen zelfdoding
Author: admin1 Oct
De psychiater doet niet genoeg tegen zelfdoding
Lees meer..
Relatie geboortegewicht en borstkanker
Author: admin1 Oct
Relatie geboortegewicht en borstkanker
Lees meer..
Solvay Pharmaceuticals scratches plan for Birmingham plant
Author: admin1 Oct
Solvay Pharmaceuticals Inc. has scrapped plans to build a $300 million flu drug plant which Birmingham Mayor Larry Langford said was destined for the city.
FDA clears Applied Biosystems influenza test instrument
Author: admin1 Oct
Applied Biosystems Inc. on Tuesday announced that the Food and Drug Administration approved an instrument for influenza virus detection. (ABI)
FDA clears Applied Biosystems influenza test instrument
Author: admin1 Oct
Applied Biosystems Inc. on Tuesday announced that the Food and Drug Administration approved an instrument for influenza virus detection. (ABI)
Metabolex adds QuatRx CEO to board
Author: admin1 Oct
Diabetes drug company Metabolex Inc. added Robert Zerbe, M.D., to its board of directors. (PFE) (APPA) (ASTM) (ANSV)
ZenBio lands $1.3M Phase II SBIR grant
Author: admin1 Oct
Biotechnology company ZenBio has received a $1.3 million grant from the National Institutes of Health to commercialize its tool for type 2 diabetes and obesity research, the company announced Tuesday.
Indevus to test treatment for hormonal disorder
Author: admin1 Oct
Indevus Pharmaceuticals Inc. has launched a late-stage human clinical trial to treat a hormonal disorder that can lead to enlarged bones and muscles.
APT Pharmaceuticals raises $32 million
Author: admin1 Oct
Komen organization gives $19M research boost to M.D. Anderson
Author: admin1 Oct
The University of Texas M.D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure while the University of Texas Medical Branch at Galveston has been awarded $600,000 for continuing research into breast cancer.
